|[February 25, 2013]
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders
NEW YORK --(Business Wire)--
Kirby McInerney LLP is investigating potential claims against the Board
of Directors of Cornerstone Therapeutics Inc. ("Cornerstone" or the
"Company") (Nasdaq: CRTX) related to the proposed acquisition of the
Company by Chiesi Farmaceutici S.p.A. ("Chiesi"). Under the terms of the
agreement, Chiesi will acquire all of the outstanding common stock of
Cornerstone that it does not already own for a cash purchase price of
between $6.40 and $6.70 per share.
The investigation concerns whether the Cornerstone Board of Directors is
violating its fiduciary dutiesand whether the proposed per share
consideration adequately values Cornerstone common shares.
If you are a Cornerstone shareholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org,
by telephone at (212) 699-1145 or (888) 529-4787, or by filling
out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in
securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to www.kmllp.com.
[ Back To Financial Technology's Homepage ]